October 17th, 2005 • The Conference Center • Harvard Medical School • 77 Avenue Louis Pasteur • Boston, MA 02115

Speakers


Welcome address

H.E. Jean - David LEVITTE

H.E. Jean-David LEVITTE
Ambassador of France to the United States of America

Hon. Thomas FINNERAN

Hon. Thomas FINNERAN
President of the Massachussets Biotechnology Council




Keynote Speakers

Dr. Katherine HIGH

Dr. Katherine HIGH
President of the American Society of Gene Therapy, Hematology Researcher at the Children’s Hospital of Philadelphia-PA
AAV, Mediated Gene Transfer for hemophilia.

Dr. Alain FISCHER

Dr. Alain FISCHER
Necker University Hospital, Director of INSERM Research Unit "Normal and Impaired Development of the Immune System"



Speakers

Dr. Paul BENKIMOUN

Dr. Peter ALDHOUS
San Francisco Bureau Chief of New Scientist
Gene therapy's rocky media ride, and its lessons for stem-cell therapy.

Dr. Arhel

Dr. Nathalie ARHEL
Post-doc, Pasteur Institute, Paris (replace Dr. Charneau)
HIV-1 Genome Nuclear Import and Gene Transfer Vectors: myths and reality.


Dr. Paul BENKIMOUN

Dr. Paul BENKIMOUN
Journalist, Le Monde, Paris-France
Writing on Gene Therapy for the lay reader.

Dr. Marina CAVAZZANA-CALVO

Dr. Marina CAVAZZANA-CALVO
Head of Biotherapy Department, Necker Hospital, Paris-France
Gene Therapy of Immune Deficits, clinical trials and development.

Dr. Pierre CHARNEAU

Dr. Pierre CHARNEAU
Head of the Molecular Virology and Vectorology Laboratory, Pasteur Institute, Paris-France
HIV-1 Genome Nuclear Import and Gene Transfer Vectors: myths and reality.

Dr. André CHOULIKA

Dr. André CHOULIKA
CEO, Cellectics, Romainville-France
Meganuclease based Genome Surgery.

Dr. Georges DALEY

 

Dr. Georges DALEY
Professor of Pediatrics, Children’s Hospital, Boston-MA
Stem Cells in Regenerative Medicine and Reproductive Biology.

Dr. Olivier DANOS

 

Dr. Olivier DANOS
Scientific director of Genethon, Evry-France (replace Dr. Garcia)
Gene Therapy of Duchenne Muscular Dystrophy through Exon Skipping.

Dr. Luis GARCIA

 

Dr. Luis GARCIA
Head of Research Team “Study of physio pathological processes of Duchenne Myopathy”, Genethon, Evry-France
Gene Therapy of Duchenne Muscular Dystrophy through Exon Skipping.

Mr. Philip D. Grégory

Dr. Philip D. GREGORY
Senior Director, Research for Sangamo BioSciences (replace Dr. Lanphier)
The Development of Novel Human Therapeutics Based Upon Engineered Zinc Finger DNA Binding Proteins.

Dr. François GROS

Dr. François GROS
Permanent Secretary, French Academy of Science, Paris-France
From Molecular Biology to Gene Therapy: an historical perspective.

Dr. Rudolf JAENISCH

Dr. Rudolf JAENISCH
Professor of Biology, Massachusetts Institute of Technology, Boston-MA
Stem Cells, Nuclear Cloning and Reprogramming of the Genome.

Dr. Philippe LEBOULCH Dr. Philippe LEBOULCH
Associate Professor of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston - MA; Vice-President & Chief Scientific Officer, Genetix Pharmaceuticals, Cambridge-MA
Lentivirus-Mediated Gene Therapy of sickle cell disease and beta-thalassemia.
Dr. Philippe MOULLIER

Dr. Philippe MOULLIER
Director of The Gene Therapy Laboratory, University of Nantes-France, Inserm U649 “Viral vectors and gene transfer in vivo”
Will be replaced by Fabienne Rolling.

Dr. Robert MULLIGAN

Dr. Richard C. MULLIGAN
Professor of Genetics at Harvard Medical School, Director of the Harvard Gene Therapy Initiative, Boston-MA
New Technologies for Improving the Safety of Gene Therapy.

Dr. Robert MULLIGAN

Dr. Fabienne ROLLING
University of Nantes, Inserm Unit 649 «Viral vectors and gene transfer in vivo». (replace Dr. Moullier)
Restoration of vision in RPE-/- dogs using rAAV serotype 4 vector that specifically target the retinal pigmented epithelium.

Dr. Philippe SLOS

Dr. Philippe SLOS
Head of the Preclinical Regulatory Department of Transgene SA, Strasbourg-France
Cancer Immunotherapy with viral vectors.